National Access Director - East

Pierre Fabre Pharmaceuticals (USA); New York (NY); Remote; USD 200,000 - 270,000; Full time

Benefits offered by this job

Bonus program

Comprehensive benefits package

Paid time off (PTO)

Job summary

Pierre Fabre Pharmaceuticals Inc. is seeking a National Access Director to lead market access preparations for Tab‑Cel (tabelecleucel) launch in the US.

You will drive payer education, pre/post‑approval information exchange, and reimbursement readiness across national and regional payers and treatment centers. Responsibilities include shaping access strategy, engaging with Medicare/VA segments, and coordinating with Field Medical, Cell Therapy Account Directors, and other stakeholders to ensure

Qualifications

• Strong, pre-existing working experience with national and regional payers that manage medical and pharmacy benefit policy.
• Deep knowledge of inpatient and outpatient reimbursement dynamics and hospital access economics.
• 10+ years in biotech/pharma with at least two years in coverage and reimbursement of complex advanced therapies (cell/gene therapy).

Responsibilities

• Operate in compliance with all laws, regulations and Pierre Fabre policies.
• Educate payer segments and treatment-center stakeholders on value proposition of Tab-Cel to enable urgent access.
• Monitor payer trends, policy changes, and implications for market access strategy.
• Collaborate with cross-functional teams to align site onboarding, pre- and post-approval information exchange, and reimbursement readiness.

Skills

Payer policy expertise

Healthcare reimbursement

Strategic communication

Cross-functional leadership

Stakeholder management

Job description

At Pierre Fabre Pharmaceuticals Inc. our mission is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better. We are the US pharmaceutical subsidiary of Pierre Fabre Laboratories Worldwide, a foundation-owned company with 7 decades of impact. Pierre Fabre Laboratories is a truly global healthcare company, established in 43 countries, with products distributed in 119 territories across the globe. Pierre Fabre's foundation ownership enhances our ability to focus on creating long‑term value for patients.

Building on the legacy of Pierre Fabre Laboratories, innovation is our life blood and patient experience drives everything we do. We aspire to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long‑term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action.

Pierre Fabre Pharmaceuticals is headquartered in Secaucus, NJ alongside Pierre Fabre USA Inc., a Pierre Fabre Laboratories subsidiary focused on dermatology and cosmetics.

SUMMARY:

We are looking for creative, highly motivated individuals to help prepare for the successful launch of an innovative allogeneic T‑cell immunotherapy in the US, Tabelecleucel (Tab‑Cel) which is an investigational cell therapy for the treatment of Epstein Barr positive post‑transplant lymphoproliferative disease.

The U.S. Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) resubmission for tabelecleucel (tab-cel / Ebvallo), setting a target action date of March 31, 2027, under the Prescription Drug User Fee Act (PDUFA).

The National Access Director will play a critical role in preparing for launch and facilitating urgent access to Tab‑cel once approved. In the pre‑approval phase, they will work closely with Pierre Fabre’s Cell Therapy Account Directors and Field Medical Directors to support site operational onboarding and readiness leading up to and after the anticipated approval of the Tab‑Cel. They will be responsible for pre‑ and post‑approval information exchanges with payers to ensure payers have the appropriate data and information required to enable coverage decisions and provide a pathway to coverage for patients who may be prescribed the Tab‑cel post approval. Critically, they will ensure that financial stakeholders at treating facilities and payers have timely access to information needed to navigate the preparation for the relevant prior authorization process and potential single case agreements.

This is an exciting opportunity to be part of an organization that is preparing to launch a new class of advanced therapeutics while making a meaningful impact on the lives of patients with a life‑threatening disease. Pierre Fabre Pharmaceuticals offers unique development opportunities, and we are looking for candidates that have a growth mindset and thrive in a start‑up environment that will be scaling up the Pierre Fabre presence in the US pharmaceuticals market. We value individuals who exhibit behaviors such as team collaboration, humility, innovative thinking, and patient centric approach to the business.

ESSENTIAL FUNCTIONS:

• Operate in compliance with all laws, regulations and policies that govern the conduct of Pierre Fabre activities
• Facilitate urgent access to Tab‑cel post approval by educating payer customer segment and treatment center financial stakeholders of value proposition of product
• Contributes to the US Value and Access Team by monitoring trends, policy changes, and implications and taking ownership of this expertise
• Seek opportunities for synergy and partnership to achieve both Pierre Fabre and customer goals through active and transparent planning and customer engagement with cross functional Team

Tab‑Cel Support

• Enable payer coverage assessment for Tab‑Cel through pre‑approval information exchange and post‑approval with national and regional payers in the Commercial, Medicare, and VA sectors
• Support overall access strategy with engagement of Federal Payers and Medicare FFS
• Educate payers on the urgent unmet need and provide resources to ensure a pathway to coverage in the pre and post approval regulatory setting
• Identify appropriate payer stakeholders for the therapy and partner with payer colleagues to establish path for expedited review of cases
• Provide approved product education and health economic information to key customers in payer and provider segment to communicate the value proposition of the product.
• Ensure financial and reimbursement confidence and communicate payer coverage with providers post approval
• Partner with treatment sites and key stakeholders to educate on reimbursement process, coverage and coding details relevant for the Therapy post approval, ensuring stakeholder comfort and confidence in their reimbursement process
• Liaise with external specialty distributor counterpart(s) to meet objectives while providing a best‑in‑class experience for sites of care
• Proactively communicate payer coverage criteria to internal field teams and external site of care stakeholders
• Prepare potential treatment centers to be reimbursement ready before and after anticipated approval
• Ensure that providers and payers have timely access to information needed to navigate prior authorizations and the negotiation of single‑case agreements (e.g. coding, relevant policy, setting of care considerations)
• The National Access Director will be the primary field team member responsible for education regarding patient assistance programs at sites of care
• The National Access Director is the field expert in market access related issues related to Trade Policy National Access Director is responsible for partnering with payer relations teams at sites of care to resolve any issues regarding coverage and reimbursement

Other duties and responsibilities may be assigned as required based on evolving business needs.

REQUIRED EDUCATION AND EXPERIENCE

• Strong, pre‑existing working experience with national and regional payers that manage medical and pharmacy benefit policy
• Deep knowledge of and experience with inpatient and outpatient reimbursement methodology and dynamics and impacts to hospital access economics
• 10+ years of biotech/pharma required with at least two years of direct experience in coverage and reimbursement dynamics of complex advanced therapies (E.g. cell therapy, gene therapy, radio ligand

Strongly Preferred

• Experience with cell and gene therapy networks and Medical Director teams at payers that manage Cell Therapy products
• Strong presentation skills and executive presence
• Exceptional business acumen and hospital administrative expertise
• Cell, Gene, Stem Cell Transplant service line experience and established relationships with financial KOLs at institutions
• Ability to work in fast‑paced and dynamic environment while maintaining cross functional internal relationships and contribute to site of care account planning
• Experience with pharmacy/ therapeutics committee and high impact drug review processes at institutions

LOCATION:

US, remote, domestic travel up to 30%

Compensation and Benefits:

Anticipated Salary Range: $200,000 -$270,000

This range represents the base annual full‑time salary for all positions within the applicable job grade. The actual salary offer will depend on a range of factors including experience, education, location, and other relevant qualifications. This position is also eligible for a Pierre Fabre bonus, commission, or incentive program in addition to the base pay.

Employees will be eligible to participate in a comprehensive benefits package that includes medical, dental, and vision coverage, voluntary benefits, a 401(k) retirement plan, a generous PTO policy, paid company holidays, and paid parental leave. Additional offerings include employee discounts on our products, professional development opportunities, and access to mental health and wellness programs.

True to My Nature

Pierre Fabre is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.